ReNeuron Group PLC
LSE:RENE
ReNeuron Group PLC
Cash from Operating Activities
ReNeuron Group PLC
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
ReNeuron Group PLC
LSE:RENE
|
Cash from Operating Activities
-£5.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
19%
|
CAGR 10-Years
2%
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Operating Activities
-$160.3m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Operating Activities
-$145.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Operating Activities
-$60.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Operating Activities
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Operating Activities
£44.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
See Also
What is ReNeuron Group PLC's Cash from Operating Activities?
Cash from Operating Activities
-5.3m
GBP
Based on the financial report for Sep 30, 2023, ReNeuron Group PLC's Cash from Operating Activities amounts to -5.3m GBP.
What is ReNeuron Group PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
2%
Over the last year, the Cash from Operating Activities growth was 26%. The average annual Cash from Operating Activities growth rates for ReNeuron Group PLC have been 22% over the past three years , 19% over the past five years , and 2% over the past ten years .